For­mer No­var­tis phar­ma­ceu­ti­cals chief David Ep­stein is go­ing biotech

David Ep­stein is join­ing a long line­up of ex­ecs who are ex­chang­ing Big Phar­ma ti­tles for a promi­nent place in the biotech world. The for­mer No­var­tis phar­ma­ceu­ti­cals chief is join­ing the biotech VC Flag­ship Pi­o­neer­ing as an ex­ec­u­tive part­ner, a new role at the trend­set­ting ven­ture group.

Ep­stein’s first role as biotech en­tre­pre­neur will in­volve tak­ing the chair­man’s job at Ru­bius Ther­a­peu­tics. And he’ll be play­ing an ac­tive role in Flag­ship’s oth­er in­vest­ments, which con­cen­trate heav­i­ly on the ax­is of aca­d­e­m­ic re­search and clin­i­cal work.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN